The GOP senator objected to Secretary Kennedy's recasting of the influential advisory panel, which has sparked criticism from ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

Daiichi Sankyo has more than 120 years of experience and scientific expertise. In 2019, they entered the oncology market in the UK, through a ground-breaking collaboration with AstraZeneca.

AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion. The deal covers DS-1062, Daiichi Sankyo’s proprietary ...

Daiichi Sankyo Company, Limited (DSKYF) CEO Hiroyuki Okuzawa on Q3 2022 Results - Earnings Call Transcript SA Transcripts Tue, Feb. 01, 2022.

Daiichi Sankyo Appoints Hiroyuki Okuzawa as Chief Executive Officer https://lnkd.in/gWCFRDWC Your go-to for local business news. Follow citybiz HIROYUKI OKUZAWA, Daiichi Sankyo US ...